Injectable Drug Delivery Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025

  • Single User License $3500

Injectable Drug Delivery Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025

Status : October, 2020 | Medical Devices | PPT format

Report Digest


Global Injectable Drug Delivery Market: Snapshot

The provision of maximum and quickest form of bioavailability of the administered drug continues to remain one of the key factors why injectable drug delivery continues to remain one of the most popular ways of administering drugs in patients across the globe. The market has witnessed vast developments in the past few years in terms of injection devices available to deliver the latest generations of drugs. Evolving from the largely mechanical devices that functioned merely to deliver the drug into the body of the early times, the present-day injectable drug delivery devices work as more efficient interfaces between the medicine and the drug. The new-age devices offer a number of functions and features that improve the safety, efficacy, usability, and compliance of the drug delivery procedure.

However, one central drawback associated with injectable drug delivery devices—the fact that these devices are unable to deliver the required drug just to the targeted site to organ and not throughout the entire body—continues to be a key area of research and development. A number of companies have put in vast resources into R&D activities aimed at making injectable drug delivery more effective and a number of new companies are foraying this field of research. Thus the market is expected to witness a rise in better products.

The report offers key insights about the present growth dynamics of the market along with a detailed analysis of the factors affecting the growth of this market. The leading companies dealing in this vertical, coupled with their major contributions in this market, have also been mentioned in the study. Furthermore, an elaborate study on the chief opportunities, trends, and risk factors in the global injectable drug delivery market forms an integral part of the report.

Global Injectable Drug Delivery Market: Overview 

Injectable drug delivery is the process of administering drugs into a patient’s body through injection-based delivery devices. It allows maximum bioavailability at a rapid transportation of the pharmaceutical drug as it bypasses the first pass metabolism. Thus, it is considered to be one of the most effective routes of administration. Some of the common routes for this type of drug delivery are intramuscular, intravenous, intracardiac, intraarterial, intradermal, subcutaneous, intrathecal, and intraperitoneal. Injectable drug delivery systems find their application in autoimmune diseases, orphan diseases, hormonal disorders, and cancer. 

Global Injectable Drug Delivery Market: Key Trends 

The growing incidence of chronic diseases such as cancer and diabetes is translating into the greater global demand for injectable drug delivery systems. Rapid technological advancements and increasing focus on new product launches are ensuring that the systems being manufactured and marketed are built so as to meet the specific needs of the patients. This, in turn, is working in favor of the growth of the global injectable drug delivery market. Players in the market are also benefitting from the flourishing growth of the biologics market. Moreover, the surging demand for self-injection devices is stoking the growth of the market. 

However, the infections associated with needlestick injuries and their growing occurrence are keeping the market from realizing its utmost potential. Furthermore, the uncertainties related to reimbursement scenario are acting as an impediment to the growth of the market. 

Global Injectable Drug Delivery Market: Market Potential 

The development of novel injectable drugs has given the global injectable drug delivery market a major boost. The impact of this driver will be high in the near future with several pharmaceutical giants attempting to widen their pipelines into injectable drugs. For instance, Dr. Reddy’s Laboratories Ltd. in October 2016 announced its association with Gland Pharma Ltd. for marketing and distribution of eight injectable abbreviated new drug applications in the U.S. 

In addition, market players are acquiring or forming partnerships with injectable drug manufacturers to maximize their revenue generation. To put this in perspective, in December 2016, Baxter International purchased three manufacturing facilities and a diverse portfolio of 11 approved injectable drugs from Claris Lifesciences. 

Global Injectable Drug Delivery Market: Region-wise Outlook 

The key segments analyzed based on geography are North America, Latin America, the Middle East and Africa, Asia Pacific, and Europe. North America will be a prominent destination for players in the global injectable drug delivery. The wide base of patients suffering from autoimmune disorders and chronic diseases such as cancer and diabetes is one of the primary factors propelling the growth of the region. The continuous technological advancements and research activities in the field is also providing a competitive edge to the region over other regions. 

Asia Pacific is expected to post a noteworthy CAGR during the review period. The increasing partnerships between global participants and local players are providing a significant momentum to the market in the region. The growth of the region can also be attributed to the sizeable investments in research and development in the healthcare and pharmaceutical sectors. Emerging countries such as China and India will be at the forefront of growth, owing to the rising healthcare awareness and improving healthcare infrastructure. 

Global Injectable Drug Delivery Market: Competitive Landscape 

Players are allocating substantial funds for research and development activities to introduce innovative drug delivery systems in order to enhance their visibility in the global injectable drug delivery market. Mergers and acquisitions are commonly adopted growth strategies by key market participants to consolidate their presence. Some of the prominent companies operating in the market are Becton, Dickinson and Company, Nova Nordisk A/S, Baxter International, Sanofi, Pfizer, Schott AG, Eli Lilly and Company, and Terumo Corporation. 

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?